Bain Capital Acquires Majority Stake in Milacron Injection Molding and Extrusion Business

Bain Capital’s Special Situations team agreed to purchase an approximately 51% majority stake in the Milacron injection molding and extrusion business from Hillenbrand for $287 million, with Hillenbrand retaining roughly 49% and remaining an investor. Bain will have operational control and will partner with Milacron management to accelerate growth while Hillenbrand uses proceeds to pay down debt and focus on its core portfolio.